Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Cost Effectiveness and Resource Allocation

Fig. 3

From: A long-term cost-effectiveness analysis of cardiac resynchronisation therapy with or without defibrillator based on health claims data

Fig. 3

A Monte Carlo simulation Probabilistic sensitivity analysis CRT-P vs. CRT-D: results of 10,000 model iterations (Monte Carlo simulation). The scatterplot depicts uncertainty in the model regarding costs and life years for CRT-P patients relative to CRT-D patients. B Cost-effectiveness acceptability (CEAC) curve CRT-P vs. CRT-D. The CEAC illustrated the proportion of ICERs from the Monte Carlo simulation that was above the chosen willingness to accept a negative outcome. CRT-P: cardiac biventricular pacemaker, CRT-D: cardiac biventricular defibrillator, ICER: incremental cost-effectiveness ratio, LY: life year

Back to article page